Format

Send to

Choose Destination
Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):145-153. doi: 10.1016/j.rec.2018.01.011. Epub 2018 Mar 16.

Predictors of Need for Permanent Pacemaker Implantation and Conduction Abnormalities With a Novel Self-expanding Transcatheter Heart Valve.

[Article in English, Spanish]

Author information

1
Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technical University Munich, Munich, Germany.
2
Department of Cardiology, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany; Department of Cardiovascular Surgery, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany.
3
Klinik für Herz-, Thorax-, und herznahe Gefäßchirurgie, University of Regensburg Medical Center, Regensburg, Germany.
4
Department of Cardiovascular Surgery, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany.
5
Institut für Anästhesiologie, Deutsches Herzzentrum München, Technical University Munich, Munich, Germany.
6
Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technical University Munich, Munich, Germany; Deutsches Zentrum für Herz- und Kreislauf-Forschung (DZHK) e.V. (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
7
Herz- und Gefäßzentrum Bad Bevensen, Klinik für Kardiologie, Bad Bevensen, Germany.
8
Department of Cardiology, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany.
9
Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technical University Munich, Munich, Germany; Deutsches Zentrum für Herz- und Kreislauf-Forschung (DZHK) e.V. (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria. Electronic address: christian.hengstenberg@meduniwien.ac.at.

Abstract

INTRODUCTION AND OBJECTIVES:

The incidence of permanent pacemaker implantation (PPI) and new conduction abnormalities (CA) with the ACURATE neo (Symetis S.A., Eclubens, Switzerland) has not been studied in detail. We aimed to analyze their predictors, evaluating patient- and device-related factors, including implantation depth and device-to-annulus ratio (DAR).

METHODS:

Two analyses of a multicenter population were performed: new PPI in pacemaker-naive patients (n = 283), and PPI/new-CA in patients without prior CA or pacemaker (n = 232).

RESULTS:

A new PPI was required in 9.9% of patients, who had a higher body mass index, higher rate of right bundle branch block and bradycardia. Neither implantation depth nor DAR differed in patients with PPI compared with those without. In the multivariable analysis neither DAR (OR, 1.010; 95%CI, 0.967-1.055; P = .7) nor implantation depth (OR, 0.972; 95%CI, 0.743-1.272; P = .8) predicted PPI. Only high body mass index, bradycardia and right bundle branch block persisted as independent predictors. PPI/new-onset CA occurred in 22.8% of patients and was associated with a higher logistic EuroSCORE. Neither implantation depth nor DAR differed in patients with PPI/new-CA vs those without (7.3 ± 1.9 vs 7.1 ± 1.5mm; P = .6 and 41.0 ± 7.9 vs 42.2 ± 10.1%; P = .4). The only predictor of PPI/new-CA was a higher logistic EuroSCORE (OR, 1.039; 95%CI, [1.008-1.071]; P = .013).

CONCLUSIONS:

New PPI and new-onset CA rates were low with the ACURATE neo. These were mainly influenced by patient characteristics and not by device-depending factors.

KEYWORDS:

Alteraciones de la conducción; Conduction abnormalities; Implante de marcapasos permanente; Implante percutáneo de válvula aórtica; Permanent pacemaker implantation; Predictores; Predictors; Transcatheter aortic valve implantation

PMID:
29551701
DOI:
10.1016/j.rec.2018.01.011

Supplemental Content

Full text links

Icon for Ediciones Doyma, S.L.
Loading ...
Support Center